RU2000100362A - APPLICATION OF THE SPECIFIC ANTAGONIST OF 5HT2 RECEPTORS FOR PREPARATION OF MEDICINES SUITABLE FOR THE TREATMENT OF APNEA SYNDROME IN THE SLEEP - Google Patents
APPLICATION OF THE SPECIFIC ANTAGONIST OF 5HT2 RECEPTORS FOR PREPARATION OF MEDICINES SUITABLE FOR THE TREATMENT OF APNEA SYNDROME IN THE SLEEPInfo
- Publication number
- RU2000100362A RU2000100362A RU2000100362/14A RU2000100362A RU2000100362A RU 2000100362 A RU2000100362 A RU 2000100362A RU 2000100362/14 A RU2000100362/14 A RU 2000100362/14A RU 2000100362 A RU2000100362 A RU 2000100362A RU 2000100362 A RU2000100362 A RU 2000100362A
- Authority
- RU
- Russia
- Prior art keywords
- preparation
- treatment
- sleep
- receptors
- application
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims 3
- 201000002859 sleep apnea Diseases 0.000 title claims 3
- 102000056834 5-HT2 Serotonin Receptors Human genes 0.000 title 1
- 108091005479 5-HT2 receptors Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- VAIOZOCLKVMIMN-UHFFFAOYSA-N 4-[3-[2-(dimethylamino)ethoxyimino]-3-(2-fluorophenyl)prop-1-enyl]phenol Chemical compound C=1C=CC=C(F)C=1C(=NOCCN(C)C)C=CC1=CC=C(O)C=C1 VAIOZOCLKVMIMN-UHFFFAOYSA-N 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- RNLKLYQQDLHHBH-ABDBJYMXSA-N chembl2103845 Chemical compound OC(=O)\C=C\C(O)=O.C=1C=CC=C(F)C=1\C(=N/OCCN(C)C)\C=C\C1=CC=C(O)C=C1.C=1C=CC=C(F)C=1\C(=N/OCCN(C)C)\C=C\C1=CC=C(O)C=C1 RNLKLYQQDLHHBH-ABDBJYMXSA-N 0.000 claims 1
- VAIOZOCLKVMIMN-PRJWTAEASA-N eplivanserin Chemical compound C=1C=CC=C(F)C=1\C(=N/OCCN(C)C)\C=C\C1=CC=C(O)C=C1 VAIOZOCLKVMIMN-PRJWTAEASA-N 0.000 claims 1
- 208000001797 obstructive sleep apnea Diseases 0.000 claims 1
Claims (4)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9707998A FR2765107B1 (en) | 1997-06-26 | 1997-06-26 | USE OF A SPECIFIC 5HT2 RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF SLEEP APNEA SYNDROME |
| FR97/07998 | 1997-06-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2000100362A true RU2000100362A (en) | 2001-10-20 |
| RU2218917C2 RU2218917C2 (en) | 2003-12-20 |
Family
ID=9508467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2000100362/14A RU2218917C2 (en) | 1997-06-26 | 1998-06-02 | Application of specific antagonist of 5ht2a-receptors for preparing drugs useful for treatment of sleep apnea syndrome |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6143792A (en) |
| EP (1) | EP1014960B1 (en) |
| JP (1) | JP3503953B2 (en) |
| KR (1) | KR20010014186A (en) |
| CN (1) | CN1154485C (en) |
| AT (1) | ATE232094T1 (en) |
| AU (1) | AU728227B2 (en) |
| BG (1) | BG104038A (en) |
| BR (1) | BR9810337A (en) |
| CA (1) | CA2295119C (en) |
| CZ (1) | CZ291935B6 (en) |
| DE (1) | DE69811248T2 (en) |
| EE (1) | EE9900595A (en) |
| ES (1) | ES2191942T3 (en) |
| FR (1) | FR2765107B1 (en) |
| HU (1) | HU229058B1 (en) |
| ID (1) | ID23799A (en) |
| IL (1) | IL133632A (en) |
| IS (1) | IS2356B (en) |
| NO (1) | NO325520B1 (en) |
| NZ (1) | NZ502495A (en) |
| PL (1) | PL190723B1 (en) |
| RU (1) | RU2218917C2 (en) |
| SK (1) | SK283845B6 (en) |
| TR (1) | TR199903197T2 (en) |
| TW (1) | TW580386B (en) |
| UA (1) | UA59397C2 (en) |
| WO (1) | WO1999000119A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
| ATE324110T1 (en) | 1998-02-27 | 2006-05-15 | Univ Illinois | SUBSTANCES WITH SEROTONIN-LIKE EFFECTS FOR THE TREATMENT OF SLEEP APNEA |
| US20060241164A1 (en) * | 1998-02-27 | 2006-10-26 | The Board Of Trustees Of The University Of Illinoi | Pharmacological treatment for sleep apnea |
| FR2787328A1 (en) * | 1998-12-22 | 2000-06-23 | Sanofi Sa | Treating snoring and high resistance or resistance syndrome in the upper airways, uses 5HT(2A) or 5HT(2A-2C) receptor antagonist, e.g. 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-prop-2-en-1-one-O-2-(dimethylaminoethyl)-oxime |
| CA2371822A1 (en) * | 1999-03-01 | 2000-09-08 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| FR2804604B1 (en) * | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF USEFUL DRUGS TO FACILITATE THE STOPPAGE OF TOBACCO CONSUMPTION |
| KR20050025628A (en) * | 2002-07-19 | 2005-03-14 | 바이오비트럼 에이비 | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| AU2005319367B2 (en) * | 2004-12-20 | 2012-05-24 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
| EP2186511A1 (en) * | 2008-11-13 | 2010-05-19 | Sanofi-Aventis | Method of treating sleep disorders using eplivanserin |
| EP2266554A1 (en) * | 2009-05-26 | 2010-12-29 | Sanofi-Aventis | Method of treating sleep disorders using eplivanserin |
| WO2010055461A1 (en) * | 2008-11-13 | 2010-05-20 | Sanofi-Aventis | Method of treating sleep disorders using eplivanserin |
| WO2010079241A1 (en) | 2009-01-12 | 2010-07-15 | Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion | Use of antagonists and/or inverse agonists of cb1 receptors for the preparation of drugs that increase motor neuron excitability |
| EP2255726A1 (en) | 2009-05-26 | 2010-12-01 | Sanofi-Aventis | Spectral profile of SWS enhancing drugs |
| EP2255807A1 (en) | 2009-05-26 | 2010-12-01 | Sanofi-Aventis | Method of treating sleep disorders using the combination of eplivanserin and zolpidem |
| EP2269600A1 (en) * | 2009-07-02 | 2011-01-05 | Sanofi-Aventis | Treatment of sleep disorders using eplivanserin in COPD patients |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2639942B1 (en) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | OXIMATED PROPENONE ETHERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| EP0449561A3 (en) * | 1990-03-29 | 1992-04-01 | Eli Lilly And Company | Use of (r)-norfluoxetine in the preparation of a medicament with affinity to 5ht1c receptors |
| EP0517984A1 (en) * | 1991-06-11 | 1992-12-16 | Merrell Dow Pharmaceuticals Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
| IL103106A (en) * | 1991-09-25 | 1998-06-15 | Sanofi Elf | Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them |
| RU2043125C1 (en) * | 1992-05-15 | 1995-09-10 | Эдуард Арутюнович Петросян | Method for preventing complications induced by non- inhalation type anesthesia |
-
1997
- 1997-06-26 FR FR9707998A patent/FR2765107B1/en not_active Expired - Fee Related
-
1998
- 1998-02-06 UA UA99126961A patent/UA59397C2/en unknown
- 1998-06-02 BR BR9810337-7A patent/BR9810337A/en not_active Application Discontinuation
- 1998-06-02 PL PL98337871A patent/PL190723B1/en not_active IP Right Cessation
- 1998-06-02 NZ NZ502495A patent/NZ502495A/en not_active IP Right Cessation
- 1998-06-02 RU RU2000100362/14A patent/RU2218917C2/en not_active IP Right Cessation
- 1998-06-02 CN CNB988077329A patent/CN1154485C/en not_active Expired - Fee Related
- 1998-06-02 US US09/446,484 patent/US6143792A/en not_active Expired - Lifetime
- 1998-06-02 DE DE69811248T patent/DE69811248T2/en not_active Expired - Lifetime
- 1998-06-02 EE EEP199900595A patent/EE9900595A/en unknown
- 1998-06-02 EP EP98928407A patent/EP1014960B1/en not_active Expired - Lifetime
- 1998-06-02 JP JP50337099A patent/JP3503953B2/en not_active Expired - Fee Related
- 1998-06-02 CA CA002295119A patent/CA2295119C/en not_active Expired - Fee Related
- 1998-06-02 IL IL13363298A patent/IL133632A/en not_active IP Right Cessation
- 1998-06-02 ES ES98928407T patent/ES2191942T3/en not_active Expired - Lifetime
- 1998-06-02 AU AU80243/98A patent/AU728227B2/en not_active Ceased
- 1998-06-02 AT AT98928407T patent/ATE232094T1/en active
- 1998-06-02 KR KR19997012261A patent/KR20010014186A/en not_active Withdrawn
- 1998-06-02 ID IDW991677A patent/ID23799A/en unknown
- 1998-06-02 WO PCT/FR1998/001100 patent/WO1999000119A1/en not_active Ceased
- 1998-06-02 SK SK1845-99A patent/SK283845B6/en not_active IP Right Cessation
- 1998-06-02 CZ CZ19994695A patent/CZ291935B6/en not_active IP Right Cessation
- 1998-06-02 TR TR1999/03197T patent/TR199903197T2/en unknown
- 1998-06-02 HU HU0002170A patent/HU229058B1/en not_active IP Right Cessation
- 1998-11-23 TW TW087119387A patent/TW580386B/en not_active IP Right Cessation
-
1999
- 1999-12-21 IS IS5316A patent/IS2356B/en unknown
- 1999-12-22 BG BG104038A patent/BG104038A/en unknown
- 1999-12-23 NO NO19996442A patent/NO325520B1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2000100362A (en) | APPLICATION OF THE SPECIFIC ANTAGONIST OF 5HT2 RECEPTORS FOR PREPARATION OF MEDICINES SUITABLE FOR THE TREATMENT OF APNEA SYNDROME IN THE SLEEP | |
| RU2218917C2 (en) | Application of specific antagonist of 5ht2a-receptors for preparing drugs useful for treatment of sleep apnea syndrome | |
| EE9600118A (en) | New oral pharmaceutical dosage form | |
| HUP0201623A3 (en) | Use of (s,s)reboxetine a selective norepinephrine reuptake inhibitor for the preparation of pharmaceutical compositions treating disorders of the nervous system | |
| EE200200274A (en) | Use of a pyrrolidine acetamide derivative in the manufacture of a medicament for the treatment of disorders of the central nervous system, and a pharmaceutical composition | |
| HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
| CA2386690A1 (en) | Pharmaceutical tramadol salts | |
| CA2364718A1 (en) | Monoamine reuptake inhibitors for treatment of cns disorders | |
| EP1426375A3 (en) | Analgesic spiroindole derivatives | |
| IL179017A0 (en) | Solid oral dosage form comprising valsartan | |
| EE200300167A (en) | Amidoalkylpiperidine and Piperazine Derivatives, Pharmaceutical Composition Containing Them, and Use of Compounds for the Treatment of Nervous System Disorders | |
| AU4058000A (en) | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors | |
| BR9809071A (en) | Pharmacological agents | |
| EE9700014A (en) | New oral dosage form containing the magnesium salt of omeprazole | |
| EE04905B1 (en) | Use of Pidasidino [4,5-b] Indole-1-Acetamide Derivatives for the Preparation of Medicines for the Treatment of Disorders Associated with Peripheral Benzodiazepine Receptor Dysfunction | |
| EP1440691A3 (en) | Treatment of neurotic disorders | |
| ZA200107143B (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders. | |
| JP2001513504A5 (en) | ||
| WO2000048445A3 (en) | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence | |
| IL177626A0 (en) | Pharmaceutical compositions for treating sleep apnoea | |
| WO2000037068B1 (en) | Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways | |
| NO20032006L (en) | Use of melagatran for the manufacture of a medicament for the treatment of ischemic disorders | |
| IL150403A0 (en) | NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | |
| IL150402A0 (en) | NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | |
| MXPA01009468A (en) | Treatment of pulmonary hypertension. |